These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 32588527)
1. Cariprazine treatment of borderline personality disorder: A case report. Grant JE; Chamberlain SR Psychiatry Clin Neurosci; 2020 Sep; 74(9):511-512. PubMed ID: 32588527 [No Abstract] [Full Text] [Related]
2. The effect of add-on treatment with quetiapine on measures of depression, aggression, irritability and suicidal tendencies in children and adolescents. Podobnik J; Foller Podobnik I; Grgic N; Marcinko D; Pivac N Psychopharmacology (Berl); 2012 Apr; 220(3):639-41. PubMed ID: 22173852 [No Abstract] [Full Text] [Related]
3. Inhaled Loxapine for Acute Treatment of Agitation in Patients With Borderline Personality Disorder: A Case Series. Kahl KG; Negt P; Wollmer A; Jung S; Kruger TH J Clin Psychopharmacol; 2015 Dec; 35(6):741-3. PubMed ID: 26448403 [No Abstract] [Full Text] [Related]
4. Long-Acting Aripiprazole in Comorbid Bipolar Disorder and Borderline Personality Disorder and Substance Abuse. Martínez JS; Caballero AR J Clin Psychopharmacol; 2017 Apr; 37(2):266-267. PubMed ID: 28145998 [No Abstract] [Full Text] [Related]
5. Injectable atypical antipsychotics for agitation in borderline personality disorder. Pascual JC; Madre M; Soler J; Barrachina J; Campins MJ; Alvarez E; Pérez V Pharmacopsychiatry; 2006 May; 39(3):117-8. PubMed ID: 16721704 [TBL] [Abstract][Full Text] [Related]
6. Treatment of borderline personality disorder with olanzapine. Shoja-Shafti S Arch Iran Med; 2006 Oct; 9(4):403-5. PubMed ID: 17061615 [TBL] [Abstract][Full Text] [Related]
7. Is psychopharmacological treatment effective for the symptoms of borderline personality disorder (BPD)? Paris J J Psychiatry Neurosci; 1999 May; 24(3):262. PubMed ID: 10354663 [No Abstract] [Full Text] [Related]
8. New developments in the neurobiology of borderline personality disorder. Bohus M; Schmahl C; Lieb K Curr Psychiatry Rep; 2004 Feb; 6(1):43-50. PubMed ID: 14738705 [TBL] [Abstract][Full Text] [Related]
9. Clozapine in borderline personality disorder: a review of the evidence. Beri A; Boydell J Ann Clin Psychiatry; 2014 May; 26(2):139-44. PubMed ID: 24812651 [TBL] [Abstract][Full Text] [Related]
10. Asenapine in the management of impulsivity and aggressiveness in bipolar disorder and comorbid borderline personality disorder: an open-label uncontrolled study. Aguglia A; Mineo L; Rodolico A; Signorelli MS; Aguglia E Int Clin Psychopharmacol; 2018 May; 33(3):121-130. PubMed ID: 29189421 [TBL] [Abstract][Full Text] [Related]
11. Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial. Earley WR; Guo H; Németh G; Harsányi J; Thase ME Psychopharmacol Bull; 2018 Jun; 48(4):62-80. PubMed ID: 30618475 [TBL] [Abstract][Full Text] [Related]
12. Pharmacologic treatments for borderline personality disorder. Tohen M Am J Psychiatry; 2014 Nov; 171(11):1139-41. PubMed ID: 25756626 [No Abstract] [Full Text] [Related]
13. Clozapine for the Management of Suicidal Behavior in Borderline Personality Disorder Complicated by a Cancer Diagnosis: A Case Report and Review of the Literature. OʼLeary J; Purcell A; Hynes C; Huet J; Romanos M; McWilliams S J Clin Psychopharmacol; 2018 Dec; 38(6):642-644. PubMed ID: 30334867 [No Abstract] [Full Text] [Related]